Hiray Pharma Solutions is an international end-to-end small molecule chemistry CDMO, facilitating the development and manufacturing of important raw materials, key intermediates and drug substances around the world.
From our R&D and cGMP manufacturing facilities in central China (Hubei province) , our 35-acre site is growing to include 3 pilot scale facilities (one dedicated to HPAPI) and 10 commercial manufacturing facilities, forecast to include 2.6 million liters of reactors (currently 265,000 liters as of September 2022).
The foundational chemistry capabilities include hydrogenation, HPAPI, fluorine chemistry, biocatalysis, flow chemistry, batch chemistry with both electrochemistry and photochemistry under evaluation as those platforms continue to evolve and grow.
https://www.youtube.com/watch?v=dDI8MvKAF2k
We provide the best chemical techniques, control, and manufacturing services to pharmaceutical and innovative enterprises, and a swift path for medicine to benefit patients.
As an end-to-end CDMO, Hiray can provide on-time, high-quality service for Process R&D, Analytical R&D, Manufacturing, and Quality Control. Hiray operates in strict compliance with, or exceeds, the latest standards for safety, health and the environment.
Our commitment to protecting our environment and the health and safety of our staff is evident to everyone who enters our workplaces.
Furthermore, Hiray is committed to absolute protection of our customers’ intellectual property. Hiray’s clients are able to rest assured their project will be handled with integrity and skill, and their product will be delivered on-time.
Hiray Pharma Solutions: Reverence for Life. Safety First. Quality Always. On-Time Delivery